control of protein acetylation. Here we describe the allosteric activation mechanism of M. tuberculosis PAT. The crystal structures of the autoinhibited and cAMP-activated PAT reveal that cAMP binds to a cryptic site in the regulatory domain that is over 32 Å from the catalytic site. An extensive conformational rearrangement relieves this autoinhibition by means of a substrate-mimicking lid that covers the protein-substrate binding surface. A steric double latch couples the domains by harnessing a classic, cAMPmediated conformational switch. The structures suggest general features that enable the evolution of long-range communication between linked domains.
Protein domains have long been recognized as functionally modular 1 . Domain shuffling in exons in eukaryotes, for example, enables the rapid duplication and divergence of protein families 2, 3 . Recombination produces numerous assortments of domains that mediate hybrid processes 4 , and domain fusions signal cooperating activities 5 . Researchers have previously proposed that domain fusions are a common initial step in the evolution of allosteric regulation 6 , but this view of the structural autonomy of domains as beads on a string has turned attention away from the question of how domains evolve to work in concert to enable tight functional regulation 7 . Here we explore the particularly pronounced mechanisms of functional domain interdependence in the cAMP-regulated PAT of M. tuberculosis.
Reversible protein acetylation is a key regulatory mechanism that controls numerous cellular processes in all three kingdoms of life 8, 9 . Proteomic studies in prokaryotes and eukaryotes have detected thousands of lysine-acetylated proteins, a number that rivals that of the phosphoproteins 9 . Protein lysine acetylation controls diverse cellular processes, including chromatin structure, chromosomal segregation, cytoskeletal dynamics and chaperone function. The emerging role for this modification in controlling mitochondrial metabolism 10, 11 highlights the remarkable conservation of this regulatory strategy. Recent discoveries have revealed that protein lysine acetylation globally regulates carbon metabolism in diverse bacterial species [12] [13] [14] . Stimuli such as varying carbon sources alter the acetylation patterns of more than 100 proteins in both E. coli and Salmonella to change the direction of carbon flux to glycolysis or gluconeogenesis and control the activity of the glyoxylate shunt relative to the tricarboxylic acid cycle. However, distinct networks couple protein acetylation to growth conditions in prokaryotes 15 .
In enteric bacteria, Gcn5-related N-acetyltransferase (GNAT) PAT activity is controlled at the transcriptional level 16 . Increases in the concentration of cAMP, a universal second messenger that modulates diverse functions in response to environmental conditions, indirectly mediate this transcriptional stimulation. The catabolite activator protein (CAP)-cAMP complex induces the expression of genes for pathways that are required for the use of alternative carbon sources or, in the absence of other substrates, restructures the central carbon metabolism for slow growth 17 . Indeed, cAMP has been shown to be the dominant regulator controlling carbon fluxes in glucose-limited cultures. The E. coli patZ acetyltransferase gene, for example, is activated approximately ten-fold by entry into the stationary phase or growth on acetate compared to growth on glucose 16 . Binding of the CAP-cAMP complex to two sites in the patZ promoter mediates this transcriptional activation.
In contrast, in M. tuberculosis, cAMP directly activates the single Gcn5-like enzyme, Rv0998 (ref. 18 ), which we call here Mt-PatA. cAMP mediates this allosteric regulation by binding to a cyclic nucleotidebinding domain fused to the N terminus of the catalytic PAT domain 18 . Although the substrates of Mt-PatA have not been globally identified, it has been proposed to inhibit the acetate catabolic enzyme, acetyl coenzyme A (acetyl-CoA) synthetase (ACS) 19 . Though no conditions have been found in which Mt-PatA acetylates purified ACS in vitro, the purified Mycobacterium smegmatis ortholog of Mt-PatA (MSMEG_5458) acetylates both M. smegmatis and M. tuberculosis ACS 19 . The universal a r t i c l e s stress protein (USP; MSMEG_4207), a homolog of proteins involved in adaptation to growth-limiting conditions 20 , is an in vitro substrate of the PatA of both mycobacteria 18 . However, M. tuberculosis lacks a USP protein, making it a nonphysiological substrate. Nonetheless, in vitro acetylation of USP has enabled the characterization of Mt-PatA activity and regulation 18 . The M. tuberculosis NAD +dependent deacetylase, Rv1151c, reverses Mt-PatA modifications and creates a reversible protein acetylation system 18, 19 .
The biological functions of Mt-PatA in adapting to different carbon sources and shifting to slow growth seem to have been conserved across diverse bacteria [12] [13] [14] 21 , but the allosteric mechanism by which cAMP regulates protein acetylation is specific to mycobacteria. To understand how distinct, functionally independent domains can be fused to enable this unique control strategy, we determined the structures of the autoinhibited and cAMP-activated states of Mt-PatA. We found that sequences inserted in the PAT domain of Mt-PatA simultaneously regulate the accessibility of the regulatory and catalytic sites. This switch harnesses a major conformational transition in the cAMP regulatory module to control the exposure of the catalytic site that is located over 32 Å away in the structures. The Mt-PatA structures provide insights into the functional requirements of the evolutionary steps after domain fusion that amplify emergent allosteric regulation.
RESULTS

Structure of Mt-PatA
The Mt-PatA sequence contains an N-terminal cNMP-binding domain (residues 12-142) fused to a GNAT-family catalytic domain (residues 146-314) followed by a C-terminal extension (residues 315-333).
To determine how the regulatory and catalytic domains are linked together to enable cAMP to control catalytic activity, we determined the crystal structures of the autoinhibited and active forms of Mt-PatA ( Table 1) . Despite the absence of acetyl-CoA in the crystallization conditions, the structures contained this substrate carried through the purification process from intracellular pools. We determined the structure of the active cAMP complex in two crystal forms at resolutions of 1.8 Å and 2.8 Å. Because the structures of the monomers derived from different space groups are similar (r.m.s. deviation of 0.70 Å for all 327 Cα atoms), we used the higher-resolution structure to represent the active conformation.
The structure of Mt-PatA in the absence of cAMP at a 1.7-Å resolution ( Fig. 1a) revealed that the enzyme is autoinhibited through at least two mechanisms. First, although the cNMP-binding domain adopts the fold of a typical cAMP-binding regulatory module ( Supplementary  Fig. 1a ), the C terminus of the protein occupies the cAMP-binding site, excluding the activator (Fig. 1b) . The C-terminal extension forms a helix that is just long enough to project the terminal carboxylate into the cryptic activator site, where it structurally mimics a bound cyclic phosphate group. A short extended loop (residues 143-145) packed against the C-terminal helix tightly links the two functional domains. Second, the PAT domain shows structural homology to the GNAT family ( Supplementary Fig. 1c ), but a large loop (residues 161-203) integrated into the catalytic domain forms a lid that folds over the catalytic site and excludes protein substrates ( Fig. 1a) . Acetyl-CoA binds in a shallow cleft formed by structurally conserved motifs 22 (Fig. 1c) . Notably, His173 in the lid engages the predicted catalytic base, Glu235, npg a r t i c l e s and the activated acetyl group, analogous to a lysine substrate ( Fig. 1d) .
Thus, the C-terminal helix and the lid are dedicated regulatory elements of the PAT domain that form a steric double latch that limits enzyme activity. The regulatory and catalytic sites are separated by over 32 Å, raising the question of what the mechanism of long-range communication between the domains is.
Structure of the active Mt-PatA-cAMP-acetyl-CoA complex
Major conformational changes accompany cAMP binding to the regulatory domain (Fig. 2) . A difference-distance matrix revealed relative structural shifts of up to 40 Å ( Fig. 2a) . The regulatory domain pivots ~40° around Ser144 in the interdomain linker, resulting in a markedly different orientation with respect to the catalytic domain ( Fig. 2b) . This rotation removes the C terminus from the cAMP-binding site. In the cAMP-activated Mt-PatA, the 44-residue lid refolds, exposing the catalytic site, further burying the acetyl-CoA substrate and revealing a conserved surface adjacent to the substrate-binding site ( Fig. 2c) .
Tertiary changes in the regulatory domain stabilized by cAMP are coupled to the release of the lid from the PAT active site. Whereas the topology of the regulatory domain is retained in the autoinhibited and active forms of Mt-PatA (r.m.s. deviation of 2.76 Å for all 134 Cα atoms), the β-sheet is the rigid element in the structure (Cα r.m.s. deviation of 0.85 Å for residues 37-113; Fig. 3a ). The α-helices that start and end the domain shift and undergo tertiary structural changes ( Supplementary Fig. 2a ). Rotating around Gly113, helices C (residues 26-35), E (residues 115-123) and F (residues 127-142) move >10 Å relative to the β-sheet to enable Arg138 and Phe142 to sandwich the adenine ring against Val67 in the sheet (Fig. 3a,b) . This altered conformation of helix F completes the cAMP-binding site.
To define the side chain shifts that enable these large structural changes, we systematically compared the rotamer distributions in the autoinhibited and cAMP-activated structures using the program Ringer 23 . Ringer automatically samples the electron density map around each side chain dihedral angle, and the correlation coefficients (ccs) of the plots generated by Ringer can highlight changes in rotamer ensembles even when the underlying models are similar 23, 24 . npg a r t i c l e s Although distributions with ccs <0.5 often differ in the major populated rotamer, we used a conservative cc threshold of 0.2 to automatically define sites that switch rotamers between the two structures ( Supplementary Fig. 2b,c) . In typical control structures in the Protein Data Bank in which changes in crystal packing are the only perturbations, very few residues give Ringer correlation coefficients <0.2 ( Supplementary Fig. 2d,e ). In contrast, Mt-PatA activation is associated with extensive remodeling of side chain distributions ( Fig. 3c,d and Supplementary Fig. 2c ). Residues in helices A, B, C and E, as well as the underlying β-sheet of the regulatory domain, adopt new rotamers after cAMP binding (Fig. 3c) . The refolding of the lid remodels rotamers on the surface of the protein from helix E all the way to the active site ( Fig. 3d and Supplementary  Fig. 2c ). The newly exposed, conserved surface ( Fig. 2c) near the acetyl donor populates many new rotamers. In contrast, the core of the PAT domain and most of the C-terminal helix retain similar structures after activation.
Communication between the regulatory and catalytic domains
A comparison of the structures of autoinhibited and active Mt-PatA revealed that the regulatory and catalytic domains communicate with each other by forming sterically incompatible conformations in the two states. In the autoinhibited state, helix F of the regulatory domain is nearly parallel to helix I (residues 193-202) of the lid domain. However, helix F reorients in the active conformation as a result of the rotation of the regulatory domain, which requires a movement of the lid to avoid steric clashes between these helices (Fig. 3e) .
The lid domain then refolds into a distinct backbone arrangement (Supplementary Fig. 3a) . Many lid residues move >15 Å, and helix I rotates toward the catalytic domain by 65° ( Fig. 3e) . cAMP favors the 'open' state of the two steric latches by stabilizing a rotation of the regulatory domain that creates the activator-binding site and simultaneously generates a steric clash with the inhibitory structure of the lid. Refolding of the lid enables the rotation of the regulatory domain that creates the cAMP-binding site.
The comparison of the active and autoinhibited structures suggested that activation by cAMP stabilizes the open lid. To test this two-state coupling model, we took advantage of the mimicry of a bound substrate by His173 in the autoinhibited conformation and substituted a lysine at this position. The lack of conservation of this residue in the closely related M. smegmatis Mt-PatA ortholog suggests that its main role is to block substrate access in the absence of cAMP. The H173K mutation introduced the only lysine in the sequence. Consistently with the close approach of His173 to the acetyl donor ( Fig. 1d) , we found that the H173K mutant readily autoacetylated the new lysine in the absence of cAMP (Fig. 4a ). The addition of cAMP blocked this autoacetylation, which is consistent with the structure of the active state in which His173 in the open lid is 25 Å away from the acetyl donor ( Supplementary  Fig. 3b ). In contrast, cAMP stimulated the acetylation of the M. smegmatis USP by the H173K variant ( Fig. 4b) , indicating that the mutation did not alter the normal regulation of the enzyme.
A two-state model further predicts that the autoinhibited structure stabilizes the closed conformation of the lid in which the acetylated Lys173 is buried, whereas cAMP stabilizes the active form in which residue 173 is fully exposed to the solvent. To test the accessibility of the acetylated Lys173, we measured the activity of the deacetylase, Rv1151c, in the presence and absence of cAMP. Under conditions in which the autoacetylated Mt-PatA H173K mutant was fully deacetylated in <10 min in the presence of cAMP, the autoinhibited form protected the acetylated Lys173 for >2 h (Fig. 4c) . In contrast, cAMP did not affect the deacetylation of a control substrate, M. smegmatis USP (Fig. 4c) . These results suggest that the lid is not simply a flexible element but instead forms alternate structures in the presence and absence of cAMP, a possibility that is in agreement with the distinct arrangements observed in the crystal structures of the active and autoinhibited states ( Figs. 2b and 3e and Supplementary Fig. 3) .
To investigate the role of the C-terminal helix in forming a steric latch, we changed the length of Mt-PatA by adding or subtracting residues. Notably, deleting the last four residues, which removes a r t i c l e s the C terminus from the cAMP-binding site, preserved the activity and activation by cAMP but imparted low acetyltransferase activity, even in the absence of the activator (Fig. 4d) . Compared to this fourresidue deletion, addition of one residue (serine or arginine) at the C terminus activated the protein more strongly in the absence of cAMP. The deletion of four residues or the addition of a single residue also accelerated the deacetylation of the H173K variant ( Supplementary  Fig. 4 ), suggesting that these mutations preferentially destabilize the autoinhibited conformation. In contrast, deletions of up to three residues that maintain crucial contacts in the autoinhibited structure (including in the polar network formed by Asp73, Arg326 and Glu330; Supplementary Fig. 4h ) preserved the autoinhibition and the deacetylation pattern. Moreover, nonphysiological high concentrations of cGMP and cCMP also activated the enzyme ( Supplementary  Fig. 5a ), and mutations of conserved residues in the cAMP-binding site blocked its activation (Fig. 4e) . These results implicate the C-terminal steric latch in the conformational switch of helix F and the rotation of the regulatory domain in activating Mt-PatA. The activation by C-terminal insertions or deletions suggests that cAMP stabilizes an intrinsic active population of the enzyme rather than inducing a specific new structure.
Activity of the PAT domain
The central catalytic core of the PAT domain is structurally homologous to other GNAT-family proteins (Supplementary Fig. 1c ).
In the active conformation of Mt-PatA, the open lid forms a conserved surface adjacent to the substrate-binding site (Fig. 2c) that creates a narrow tunnel that allows the side chain of the substrate lysine to access the acetyl donor (Fig. 5a) . The entrance to the cavity is surrounded by Glu235, the conserved catalytic base, Arg184, which is positioned to reduce the pK a of the substrate lysine, and the hydrophobic surfaces of the side chains (for example, Phe185, Arg223, Val225 and Ala237) that can complement the aliphatic tail of the lysine acceptor ( Fig. 5b) . Arg184 is particularly noteworthy, as it is buried under both the lid and Phe185 and forms a hydrogen bond to the adjacent Arg223 at the bottom of a water-filled tunnel on the backside of the lid (Fig. 5a,b) . After activation, the lid residues Arg184 and Phe185 shift >25 Å (Supplementary Fig. 3b,c) .
Mutational analyses emphasize the importance of these residues for catalyzing acetyl transfer. The E235A mutation abolished any detectable transfer activity, and mutations of residues potentially involved in the complementary interaction with the aliphatic tail of the substrate lysine substantially decreased (R223A and V225A) or Figs. 4e and 5c) . The R223A variant showed markedly reduced activity, with an altered pH-rate profile (Fig. 5c) . The R223A mutation abolished direct interactions with Arg184, which is consistent with a dual role for this network of residues in providing the binding site for the substrate and lowering the pK a of the nucleophile of the lysine ε amino group.
The presence of a cavity beyond the acetyl donor led us to measure the relative activities of different substrates (acetyl-CoA, propionyl-CoA and butyryl-CoA) on USP, a heterologous, noncognate protein substrate (Supplementary Fig. 5b-d) . The addition of an excess of an equimolar mixture of the three CoA donors resulted in a 1.0:1.6:1.3 ratio of acetyl-USP to propionyl-USP to butyryl-USP (Supplementary Fig. 5e ). These results suggest that Mt-PatA can efficiently turn over alternative acyl donors. Accordingly, it may be useful to characterize the distributions and functions of these alternative modifications in cells. As acetylation and propionylation have been shown to regulate pathways necessary for the assimilation of acetate and propionate, respectively 19, 25 , it will be interesting to determine whether these modifications have distinct effects on target enzymes.
DISCUSSION
In this work, we have defined the unique mechanism by which mycobacteria couple cAMP concentration to protein lysine acetylation. Our structural and biochemical analysis defines two distinct functional states of the acetyltransferase Mt-PatA. Major structural changes required for cAMP binding are coupled to exposure of the catalytic site. In the autoinhibited state of Mt-PatA, the cAMP-binding site is blocked by the C-terminal helix from the catalytic domain. In addition, the substrate-mimicking lid in the catalytic domain buries the acetyl donor and a conserved surface that forms the protein-substrate binding site. While excluding the C terminus, cAMP stabilizes the rotation of the regulatory domain, as well as tertiary shifts that are incompatible with the closed lid. These shifts release the steric double latch created by the lid and the C-terminal extension of the PAT domain (Fig. 6) . The lid rearranges in the active state, creating a large binding surface for protein substrates.
Our results disfavor a sequential model in which cAMP binding initiates a specific mechanical pathway for the conformational change. Crucially, there is no site for cAMP to bind before the enzyme switches conformations (Fig. 1) , and once cAMP stabilizes the active form, the lid does not readily fluctuate back to the inhibited conformation (Figs. 2-4 and Supplementary Figs. 3 and 4) . In addition, C-terminal mutations designed to destabilize the latch at the regulatory site activate the enzyme in the absence of cAMP (Fig. 4d) . This gain of function shows that cAMP is not needed to induce the active conformation in the mutants. These findings support a two-state model for activation that is mediated by the steric incompatibility of the alternate conformations. In this model, the relative stability of the two globally different conformations mediates the communication between the regulatory and catalytic sites. Consistent with changes in hydrogen exchange in peptides throughout the protein after cAMP binding 26 , the widespread changes in rotamers detected using Ringer and the effects of diverse mutations on activation provide evidence that changes in interactions throughout the enzyme determine the relative stability of the two states.
Diverse proteins containing a cAMP-binding module-including CAP, hyperpolarization-activated cyclic nucleotide-modulated channels and the regulatory subunit of protein kinase A-have been structurally characterized. Although these proteins mediate different biological functions, they all contain a conserved module for cAMP binding that allosterically controls activity 27, 28 . The cAMP-binding modules have similar architectures but have substantial structural variations in the helical subdomain and the loop between strands 4 and 5 (according to Mt-PatA numbering; Supplementary Fig. 2) . The core β-subdomain is structurally similar (r.m.s. deviation of 0.73-1.00 Å for ~70 Cα atoms of Mt-PatA; Supplementary Fig. 1a) ,
Ac-USP pH 10 pH 9 pH 8 pH 7 pH 6 pH 5 pH 4 Figure 5 The open lid in the active state uncovers a cavity for the substrate lysine. (a) A surface representation of the active conformation showing the access tunnel for the substrate lysine. Residues in the lid (cyan) and the conserved catalytic domain (magenta) form the surface surrounding the tunnel. Acetyl-CoA (sticks) projects the acetyl group (green carbon atoms) and the sulfur of the leaving group (gold) into the active site. (b) Ribbon diagram of the binding surface for the substrate lysine in the same view and colors as in a. The hydrogen bond between Arg184 and Arg223 is shown as a dotted line. (c) Catalytic-site mutants reveal residues crucial for acetyl transfer. The pH dependence of the activity of wild-type (WT) (with the activity at pH 8 at least that at pH 9) and R223A (activity at pH 9 greater than that at pH 8) variants suggest the key role of Arg223 in modulating the pK a of the substrate lysine. Ac-USP, acetylated USP. npg a r t i c l e s and the key residues that interact with cAMP also are conserved among the cAMP-binding modules (Supplementary Fig. 1b) . cAMP binding to Mt-PatA requires a >10-Å movement of helix F (residues 127-142) in the regulatory domain. Similarly, in E. coli CAP [28] [29] [30] , cAMP stabilizes a restructuring in the helix containing cAMP-binding residues that is linked to a coil-to-helix transition, with many residues moving >10 Å (Supplementary Fig. 6a-c) . These changes result in steric clashes that are resolved by flipping out the DNA-binding domains of CAP. The solution structure of apoCAP determined using NMR shows that the cAMP-binding site is not present in the major conformer in the absence of an activator 28 . This is reminiscent of the cryptic cAMP site of Mt-PatA and suggests that the conformation switches before the nucleotide binds. Moreover, NMR measurements show that two constitutively activating CAP mutations switch the population toward the active conformation in the absence of an activator 28 , as embodied in the design of the C-terminal mutants of Mt-PatA (Fig. 4d) . In contrast, the cAMP-binding site is better formed in the crystal structure of apoCAP, and the crystallographic results have been interpreted in terms of a sequential activation model 30 . Nonetheless, genetic, biochemical and NMR studies of E. coli CAP 28 indicate that the two-state model for Mt-PatA activation captures the general features of cAMP-regulated systems.
Large structural shifts also occur in the RIα inhibitory subunit of human cAMP-dependent protein kinase, where cAMP binding stabilizes major conformational changes through the connecting B/C helix that release the regulatory subunit 31 . These examples emphasize the general role of the cAMP-binding domain in regulating large conformational changes but not subtle shifts 32 . By modulating the position of the helical subdomain, cAMP binding favors structural changes that must be accommodated in the attached functional domains by changes that are commensurate in magnitude 32 . Although cAMP mediates large structural shifts, the structural responses in the regulated domains are distinct in different systems (Supplementary Fig. 6d-g) .
The selective pressures that shaped the evolution of the regulation of Mt-PatA by cAMP remain to be defined. Bacterial pathogens, including M. tuberculosis, commonly use cAMP as a key regulator of gene expression and host signaling to promote survival in changing environmental conditions 15, 33 . The cellular dynamics of cAMP are determined by the interplay of synthetic adenylyl cyclases and hydrolytic cyclic nucleotide phosphodiesterases. The M. tuberculosis genome encodes ten predicted cAMP-binding proteins, one phosphodiesterase and an unusually large number of adenylyl cyclases (15 and 17 in strains H37Rv and CDC1551, respectively) 34 . In contrast, other bacterial pathogens, such as E. coli and Pseudomonas, have only one adenylyl cyclase gene. This expansion of adenylyl cyclase sequences suggests that Mt-PatA forms the nexus of multiple signaling pathways that modulate cAMP concentrations. Although the family of CAP transcription factors mediates many of the effects of cAMP, the cAMP signaling cascade in mycobacteria is remodeled to mediate direct post-translational regulation of protein lysine acetylation without the requirement for new gene expression 18 . M. tuberculosis is thought to persist in a relatively quiescent state during infection 35, 36 , and dormant mycobacteria may produce little new mRNA or protein 37 . Moreover, rapid changes in mycobacterial metabolism may be required to tolerate host immune defenses. Thus, the structure of the Mt-PatA we describe may be specialized to allow for rapid regulation under growth-limiting conditions. The conservation of the residues that contact cAMP (Supplementary Fig. 1b) , however, may hamper efforts to develop selective inhibitors that target this site in Mt-PatA in preference to human cAMP-binding domains. Rather, controlling the Mt-PatA latching mechanisms through stabilizing the autoinhibited form of the protein may be a more promising strategy for therapeutic development.
Although the evolutionary pathway of Mt-PatA cannot be appreciated experimentally, structural comparisons give clues as to the molecular features that can enable the emergence of this allosteric control. In Mt-PatA, two sequence elements in the catalytic domain and the three-residue linker between the domains harness the conformational switch in the cAMP regulatory module. The lid and the C-terminal helix inserted in the PAT domain do not make direct contacts but instead interact indirectly through the cAMP-binding module. No regulation is possible without the lid, so this was probably the first regulatory element to be incorporated. The archaeal PAT from Sulfolobus solfataricus provides an example of an isolated PAT domain with an autoinhibitory lid 38 . Without a regulatory domain, the lid in this archaeal PAT may respond directly to growth conditions. Consistent with the previously developed model 6 , fusion of the cAMP-binding domain in Mt-PatA and the evolution of interdomain interactions with the lid in the unbound form would provide an evolutionary pathway for metabolites to regulate autoinhibition. The effects of C-terminal mutations in Mt-PatA show that the addition of the C-terminal helix provides a latch that stabilizes the autoinhibited form relative to the active form, effectively increasing the cAMP concentration needed for activation. The interdomain linker tightly tethers the domains, preventing the regulatory and PAT domains from diffusing apart. This short covalent linkage restricts the relative motions of the domains to a rotation that functions to cooperatively reveal the cAMP-binding site and the active site. This cooperation of sterically incompatible conformations creates a two-state mechanism of long-range communication that couples regulatory and catalytic sites that are separated by over 32 Å. Overall, this switch in Mt-PatA offers insights into the structural features that can be exploited in the evolution of allosteric regulation through domain fusion.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Protein Data Bank: The coordinates and structure factors have been deposited with accession codes 4AVA (autoinhibited Mt-PatA), 4AVB and 4AVC (cAMP-activated Mt-PatA).
Note: Supplementary information is available in the online version of the paper.
ONLINE METHODS
Cloning of Mt-PatA and Rv1151c deacetylase from M. tuberculosis. The Rv0998 gene (GenBank CAB08156.1) was amplified by PCR from the genomic DNA of M. tuberculosis strain H37Rv using PfuTurbo DNA Polymerase (Stratagene), with unique BamHI and XhoI restriction sites introduced at the N and C terminus, respectively. Amplified, digested PCR products were ligated into the predigested pGEX-6P-3 vector (GE Healthcare), resulting in an N-terminal, cleavable, glutathione S-transferase (GST) tag followed by the Mt-PatA coding sequence. Clones were verified by DNA sequencing (Elim Biopharm).
Indel mutants of Mt-PatA were generated by PCR using the cloned wild-type Mt-PatA construct as a template. Point mutations were generated using the QuikChange method (Stratagene).
Cloning of universal stress protein MSMEG_4207 from M. smegmatis. The msmeg_4207 gene (GenBank ABK72172.1) was amplified from the genomic DNA of M. smegmatis strain MC 2 155 by similar procedures described above and cloned into the pGEX-6P-3 vector to introduce a cleavable N-terminal GST tag. Clones were verified by DNA sequencing.
Protein expression and purification. Mt-PatA variants were expressed in BL21-CodonPlus (Stratagene) cells induced with 0.1 mM IPTG and grown overnight at 22 °C. Cells were harvested by centrifugation, resuspended in 20 mM Tris-HCl, pH 7.5, and 100 mM NaCl with protease inhibitors, lysed by sonication, and the cleared lysate was purified on a GSTrap HP column (GE Healthcare). Mt-PatA-GST fractions were cleaved with PreScission Protease (GE Healthcare) and reloaded onto the GSTrap HP column, and the flow-through fractions were concentrated and purified by gel filtration on a Superdex 75 (GE Healthcare) column. Selenomethionine-labeled Mt-PatA was expressed as previously described 39 and was purified in the presence of 1 mM Tris-(2-carboxyethyl)phosphine (TCEP).
M. smegmatis USP was expressed in BL21-CodonPlus E. coli cells induced with 0.5 mM IPTG at 22 °C and purified as described above for Mt-PatA. Histagged Rv1151c deacetylase was expressed similarly, and harvested cells were resuspended in 20 mM HEPES, pH 7.5, 500 mM NaCl and 25 mM imidazole and lysed by sonication. The cleared lysate was purified on a nickel-charged HiTrap Chelating HP column (GE Healthcare) using a 25-to 300-mM imidazole gradient. The protein was concentrated and purified by gel filtration on a Superdex 75 column in 20 mM Tris-HCl, pH 7.5, and 100 mM NaCl. Deacetylation assays (20 µl) were carried out at 22 °C in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM NAD + and 20 µM autoacetylated Mt-PatA H173K mutant in the presence or absence of 200 µM cAMP. Reactions were initiated by the addition of 5 µM Rv1151c and terminated at various time points by boiling in SDS loading dye. Samples were analyzed in parallel using SDS-PAGE and western blotting with antibodies to acetylated lysine (Cell Signaling Technology, cat. no. 9441S; 1:2,000 dilution).
In vitro
H173K Mt-PatA autoacetylation. The purified Mt-PatA H173K mutant autoacetylated in vivo was deacetylated twice sequentially using Rv1151c deacetylase in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM NAD + , 10 µM Mt-PatA H173K mutant, 200 µM cAMP and 5 µM His-tagged Rv1151c. The deacetylation reaction was initiated by the addition of His-tagged Rv1151c to the reaction mixture and incubated at 22 °C for 2 h. The reaction mixture was loaded onto a nickel-charged HiTrap column, and flow-through fractions were collected, followed by dialysis against 20 mM Tris-HCl, pH 7.5, and 100 mM NaCl overnight at 4 °C. Dialyzed protein was subjected to the second deacetylation step using identical procedures to remove residual acetylated lysine formed during the dialysis as a result of the bound acetyl-CoA carried over from cells in the course of expression. The double-deacetylated H173K mutant was assayed for reacetylation in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 µM Mt-PatA H173K mutant and 100 µM acetyl-CoA in the presence or absence of 200 µM cAMP. Samples were analyzed using SDS-PAGE and western blotting.
Comparison of activity with different CoA donors. Assays were carried out in 20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 µM Mt-PatA, 200 µM cAMP, 1 mM CoA donor(s) (acetyl-CoA, propionyl-CoA or butyryl-CoA) and 100 µM M. smegmatis USP. The masses of the reaction products were determined using liquid chromatography MS.
Crystallization, structure determination and refinement. Mt-PatA-acetyl-CoA was crystallized by vapor diffusion from 100 mM sodium cacodylate, pH 6.0, 200 mM magnesium acetate and 20% (w/v) PEG 8K. Two crystal forms of Mt-PatA-acetyl-CoA-cAMP were grown by vapor diffusion from 100 mM sodium citrate, pH 5.0, 5 mM cAMP 12% (v/v) isopropanol and 15% (w/v) PEG 10K. The crystals were transferred into mother liquors containing 25% (v/v) ethylene glycol, and diffraction data were collected at 100 K. X-ray data were processed and scaled using HKL2000 (ref. 40) or Mosflm 41 and Scala 42 , respectively.
The structures of autoinhibited and cAMP-activated Mt-PatA were solved with multiwavelength anomalous dispersion phasing using Phenix AutoSol 43 . The initial models built by Phenix AutoBuild 43 were improved using ARP/wARP 44 and Coot 45 . A model of one molecule of the cAMP-bound form of Mt-PatA was used to place a second molecule in the asymmetric unit using Phaser 46 . Rigid body refinement 47 and automated modeling with Buccaneer 48 were followed by additional cycles of manual model building and refinement 43, 47 . The cAMPbound structure at a resolution of 18 Å was determined using molecular replacement 46 and refined using Phenix Refine 43 , with exclusion of 5% of the reflections to calculate R free . Translation/libration/screw refinement was incorporated at the end of the process. The molecules were packed similarly in the two crystal forms of the activated enzyme.
Ringer correlation coefficients between electron-density maps of the active and autoinhibited structures were calculated as previously described 23, 24 . Models were validated using MolProbity 49 , showing that 97.2-98.5% of all φ and ψ geometries were in the most favored region, with no outliers in the Ramachandran statistics. Sequence conservation was mapped onto the structures using ConSurf (http:// consurf.tau.ac.il/). The Pfam database (http://pfam.sanger.ac.uk/) was used to identify functional domains and related sequences. Multiple sequence alignment was performed using ClustalW2 (ref. 50). Secondary structures were assigned using the Dictionary of Protein Secondary Structure 51 , and structural figures were generated using PyMOL (http://www.pymol.org/) and Chimera 52 .
